Thrive Earlier Detection Corp. Revenue and Competitors
Estimated Revenue & Valuation
- Thrive Earlier Detection Corp.'s estimated annual revenue is currently $34.1M per year.
- Thrive Earlier Detection Corp.'s estimated revenue per employee is $193,750
- Thrive Earlier Detection Corp.'s total funding is $367M.
Employee Data
- Thrive Earlier Detection Corp. has 176 Employees.
- Thrive Earlier Detection Corp. grew their employee count by -26% last year.
Thrive Earlier Detection Corp.'s People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and Chief Innovation Partner, | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | VP, Biostatistics and Informatics | Reveal Email/Phone |
5 | Head Research And Development | Reveal Email/Phone |
6 | VP Laboratory Operations | Reveal Email/Phone |
7 | EVP & Head Product Solutions | Reveal Email/Phone |
8 | Director Payer Relations | Reveal Email/Phone |
9 | Senior Director, R&D | Reveal Email/Phone |
10 | Director Product Strategy & Patient Experience | Reveal Email/Phone |
Thrive Earlier Detection Corp. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Thrive Earlier Detection Corp.?
A cancer diagnosis is something no one wants to hear. Today, it is often detected late, once it has spread and treatment options are often limited. But cancer is curable if caught in the earlier stages. At Thrive Earlier Detection, our goal is to transform this outlook: to catch cancer earlier, when it can be more effectively treated. We are developing CancerSEEK, a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages. Our approach goes beyond a cancer diagnosis. We are developing a platform that will serve as a resource to help patients and their families maneuver the often confusing and overwhelming path that follows a cancer diagnosis.
keywords:N/A$367M
Total Funding
176
Number of Employees
$34.1M
Revenue (est)
-26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Thrive Earlier Detection Corp. News
Total first quarter revenue of $487M, including Screening revenue of ... which relates to our acquisition of Thrive Earlier Detection Corp.
The Exact Sciences' mission is to eradicate cancer by making earlier detection a routine part of medical care.
MADISON, Wis., April 26, 2022 /PRNewswire/ -- Exact Sciences Corp. ... of which relates to our acquisition of Thrive Earlier Detection Corp.
Thrive Earlier Detection has raised $257 million in a Series B led by Casdin Capital and Section 32. Other investors including Bain Capital, Janus Henderson, T. Rowe Price and Lux Capital also supported the round. The funds will help advance the company's development of a liquid biopsy test desi ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $52.6M | 177 | N/A | N/A |
#2 | $28.2M | 177 | 5% | N/A |
#3 | $32.1M | 177 | 12% | N/A |
#4 | $34.5M | 178 | 29% | $338M |
#5 | $47.6M | 178 | 1% | N/A |